We are live on ! Find out more
PLRX icon

Pliant Therapeutics
PLRX

88 hedge funds and large institutions have $416M invested in Pliant Therapeutics in 2021 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 34 increasing their positions, 13 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

162% more repeat investments, than reductions

Existing positions increased: 34 | Existing positions reduced: 13

157% more first-time investments, than exits

New positions opened: 18 | Existing positions closed: 7

14% more funds holding

Funds holding: 77 → 88 (+11)

1.08% more ownership

Funds ownership: 84.53% → 85.61% (+1.1%)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

19% less capital invested

Capital invested by funds: $512M → $416M (-$96M)

50% less call options, than puts

Call options by funds: $326K | Put options by funds: $655K

Holders
88
Holders Change
+11
Holders Change %
+14.29%
% of All Funds
1.35%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
18
Increased
34
Reduced
13
Closed
7
Calls
$326K
Puts
$655K
Net Calls
-$329K
Net Calls Change
+$483K

Top Buyers

Rank Fund Capital Flow
1
Point72 Asset Management
Point72 Asset Management
Connecticut
+$18M
2
FLAM
First Light Asset Management
Minnesota
+$6.15M
3
GIM
Granahan Investment Management
Massachusetts
+$4.34M
4
Morgan Stanley
Morgan Stanley
New York
+$3.05M
5
BlackRock
BlackRock
New York
+$2.16M

Top Sellers

Rank Fund Capital Flow
1
EAM
Eventide Asset Management
Massachusetts
-$34M
2
Vanguard Group
Vanguard Group
Pennsylvania
-$3.18M
3
WP
Woodline Partners
California
-$3.04M
4
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$420K
5
SFI
Susquehanna Fundamental Investments
Pennsylvania
-$201K
Name Holding Trade Value Shares
Change 		Change in
Stake
Jacobs Levy Equity Management
51
Jacobs Levy Equity Management
New Jersey
$196K +$231K +14,543 New
AIG
52
American International Group
New York
$173K -$6.09K -383 -3%
PPA
53
Parametric Portfolio Associates
Washington
$153K +$180K +11,320 New
CSS
54
Cubist Systematic Strategies
Connecticut
$147K +$173K +10,875 New
VEA
55
Virtus ETF Advisers
New York
$146K +$69.3K +4,361 +67%
Wells Fargo
56
Wells Fargo
California
$145K +$167K +10,508 +5,004%
CCFM
57
Clear Creek Financial Management
Washington
$144K +$169K +10,650 New
E
58
Ergoteles
New York
$142K +$167K +10,500 New
UBS Group
59
UBS Group
Switzerland
$140K +$133K +8,391 +435%
ProShare Advisors
60
ProShare Advisors
Maryland
$139K -$6.74K -424 -4%
Squarepoint
61
Squarepoint
New York
$138K +$162K +10,188 New
DCM
62
Difesa Capital Management
New York
$138K +$162K +10,200 New
JF
63
Jump Financial
Illinois
$138K +$162K +10,200 New
Invesco
64
Invesco
Georgia
$134K -$18.9K -1,190 -11%
MIM
65
MetLife Investment Management
New Jersey
$128K – – –
Citigroup
66
Citigroup
New York
$105K +$45.4K +2,858 +58%
MLICM
67
Metropolitan Life Insurance Company (MetLife)
New York
$98.7K – – –
Legal & General Group
68
Legal & General Group
United Kingdom
$78K +$572 +36 +0.6%
Royal Bank of Canada
69
Royal Bank of Canada
Ontario, Canada
$71K +$46.2K +2,905 +122%
SIC
70
Salem Investment Counselors
North Carolina
$70K +$70.2K +4,420 +556%
GWM
71
Geneos Wealth Management
Colorado
$41K – – –
SO
72
STRS Ohio
Ohio
$40K – – –
AIP
73
Ameritas Investment Partners
Nebraska
$26K – – –
TRCT
74
Tower Research Capital (TRC)
New York
$22K +$14.7K +923 +131%
PHK
75
Point72 Hong Kong
Hong Kong
$16K +$19.3K +1,217 New
1 2
3
4

PLRX Hedge Fund Activity: Q4 2021 in Review

88 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Pliant Therapeutics (PLRX) for Q4 2021, worth a combined $416M — down 19% from $512M a quarter earlier.

Buyers outnumbered sellers: 18 funds opened new PLRX positions and 7 closed out — a net gain of 11 holders — while 34 added to existing stakes and 13 trimmed.

The largest buyer was Point72 Asset Management, opening a new position worth an estimated $18M. The largest seller was Eventide Asset Management, cutting an estimated $34M.

  • 88 institutional investors held Pliant Therapeutics (PLRX) as of Q4 2021, up from 77 in Q3 2021.
  • Funds reported $416M of Pliant Therapeutics stock for Q4 2021, down 19% quarter-over-quarter.
  • 18 funds opened new Pliant Therapeutics positions in Q4 2021 and 7 closed out, a net change of +11 holders.
  • The largest Pliant Therapeutics buyer in Q4 2021 was Point72 Asset Management, an estimated $18M added.
  • The largest Pliant Therapeutics seller in Q4 2021 was Eventide Asset Management, an estimated $34M sold.

Based on aggregated 13F filings for Q4 2021.